HM242-Gel vs Comparator

  • End date
    Feb 28, 2022
  • participants needed
  • sponsor
    B. Braun Ltd. Centre of Excellence Infection Control
Updated on 31 July 2021


The primary objective of the study is to demonstrate that the HM242-Gel performs at least comparably to INTRASITE Gel with regard to wound healing.

Condition Varicose Ulcer, Venous stasis, venous ulcers, venous ulcer
Treatment Intrasite gel, HM242-Gel
Clinical Study IdentifierNCT04902651
SponsorB. Braun Ltd. Centre of Excellence Infection Control
Last Modified on31 July 2021


Yes No Not Sure

Inclusion Criteria

Males or females of at least 18 years at the time of enrolment
The legal capacity and ability to understand the nature, risks, significance and scope of the clinical trial and to determine his or her will accordingly
Signed form of consent, including the understanding of and willingness by the patient to participate in the clinical study and ability to comply with study procedures and study visit schedule
Patients must be willing to have all dressing changes performed by the wound specialist, with no treatments at home
Presence of at least one venous ulcer of the lower leg extending through the full thickness of the skin but not down to muscle, tendon or bone
Size of study ulcer 2cm and 100cm measured using the tracing method
Presence of venous leg ulcer for at least 6 weeks, but not longer than 12 months
Ankle Brachial Pressure Index (ABI) > 0.75
In the case of a female patient of childbearing potential, willingness to use highly effective methods of contraception (failure rate of < 1% when used consistently and correctly);acceptable contraceptive measures in this trial are: combined pill and progestin-only pill, contraceptive patch, ring or injection, Etonogestrel implant, intrauterine device (IUD) (copper and Levonogestrel), male sterilization (vasectomy), female sterilization (abdominal, laparoscopic, hysteroscopic), or sexual abstinence

Exclusion Criteria

Patients kept in an institution due to an official or court order
Patients dependent on the Sponsor, Investigator or Site
Patients suspected of having SARS-CoV-2 infection or COVID-19 disease
Study ulcer judged by the Investigator to be caused by a medical condition other than venous insufficiency
Study ulcer with signs and symptoms of infection, or under suspicion of cancer
Study ulcer under treatment with topical antimicrobials within past two weeks or systemic antimicrobial treatment within past two weeks
In the case of heavily exuding ulcers, if in the opinion of Investigator the patient is not suitable for treatment with gel
More than two venous leg ulcers or more than two chronic wounds
Dementia stage greater than 3 according to Reisberg
Known allergies against wound dressings used in the study
Known chronical skin diseases, dermatoses, or known allergies or other conditions which might trigger dermatitis
Acute cases of substance use disorders (ICD-10 F1x.1 or F1x.2)
Buerger's disease
Participation in Medical Device trials less than 4 weeks ago or participation in Drug trials less than six months ago
Terminally ill patients
Patients with poorly managed diabetes mellitus: absence of a glycated hemoglobin test within the last 3 months or a result of HbA1c 8% not older than 3 months, or a major diabetes-related incident within the past 4 weeks
Ulcers of diabetic origin
Patients under treatment with systemic corticosteroids, immunosuppressant, cytotoxic chemotherapy, or radiotherapy
Presence of one or more medical conditions (other than venous insufficiency and diabetes) as determined by medical history, which
Is known to interfere with the wound healing process (e.g. arteriopathy, vasculitis, rheumatoid arthritis, systemic lupus erythematosus, other auto-immune diseases, cancer, immunodeficiency, severe lymphedema of the leg, thrombophilia)
In the opinion of the Investigator, would make the patient an inappropriate candidate for this venous ulcer healing study (e.g. malnutrition, hygiene, obesity)
Pregnant or lactating patients
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note